Charles Schwab’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.89M | Buy |
99,427
+7,623
| +8% | +$283K | ﹤0.01% | 2573 |
|
|
2026
Q1 | $3.68M | Buy |
91,804
+2,977
| +3% | +$141K | ﹤0.01% | 2526 |
|
|
2025
Q4 | $3.99M | Buy |
88,827
+5,549
| +7% | +$257K | ﹤0.01% | 2550 |
|
|
2025
Q3 | $3.72M | Sell |
83,278
-67,964
| -45% | -$3.25M | ﹤0.01% | 2556 |
|
|
2025
Q2 | $7.27M | Buy |
151,242
+91,151
| +152% | +$3.96M | ﹤0.01% | 2164 |
|
|
2025
Q1 | $2.41M | Sell |
60,091
-119,737
| -67% | -$5.04M | ﹤0.01% | 2552 |
|
|
2024
Q4 | $8.24M | Buy |
179,828
+123,913
| +222% | +$5.55M | ﹤0.01% | 2102 |
|
|
2024
Q3 | $2.62M | Buy |
55,915
+1,792
| +3% | +$81.7K | ﹤0.01% | 2624 |
|
|
2024
Q2 | $2.29M | Buy |
54,123
+191
| +0.4% | +$8.38K | ﹤0.01% | 2666 |
|
|
2024
Q1 | $2.38M | Buy |
53,932
+1,645
| +3% | +$75K | ﹤0.01% | 2543 |
|
|
2023
Q4 | $2.41M | Buy |
52,287
+14,743
| +39% | +$627K | ﹤0.01% | 2556 |
|
|
2023
Q3 | $1.61M | Buy |
37,544
+1,901
| +5% | +$88.6K | ﹤0.01% | 2662 |
|
|
2023
Q2 | $1.7M | Sell |
35,643
-1,134
| -3% | -$54.7K | ﹤0.01% | 2601 |
|
|
2023
Q1 | $1.79M | Sell |
36,777
-22,401
| -38% | -$1.14M | ﹤0.01% | 2553 |
|
|
2022
Q4 | $3.13M | Buy |
59,178
+31,471
| +114% | +$1.55M | ﹤0.01% | 2418 |
|
|
2022
Q3 | $1.21M | Buy |
27,707
+1,515
| +6% | +$74.8K | ﹤0.01% | 2725 |
|
|
2022
Q2 | $1.31M | Buy |
26,192
+485
| +2% | +$23.7K | ﹤0.01% | 2696 |
|
|
2022
Q1 | $1.34M | Buy |
25,707
+2,753
| +12% | +$142K | ﹤0.01% | 2763 |
|
|
2021
Q4 | $1.35M | Buy |
22,954
+1,202
| +6% | +$68.9K | ﹤0.01% | 2803 |
|
|
2021
Q3 | $1.19M | Buy |
21,752
+1,077
| +5% | +$60K | ﹤0.01% | 2811 |
|
|
2021
Q2 | $1.06M | Buy |
20,675
+1,200
| +6% | +$62K | ﹤0.01% | 2903 |
|
|
2021
Q1 | $1.01M | Buy |
19,475
+1,509
| +8% | +$82.9K | ﹤0.01% | 2858 |
|
|
2020
Q4 | $1.01M | Buy |
17,966
+239
| +1% | +$12.8K | ﹤0.01% | 2766 |
|
|
2020
Q3 | $983K | Sell |
17,727
-1,196
| -6% | -$62K | ﹤0.01% | 2683 |
|
|
2020
Q2 | $860K | Buy |
18,923
+1,768
| +10% | +$79.1K | ﹤0.01% | 2671 |
|
|
2020
Q1 | $757K | Buy |
17,155
+2,301
| +15% | +$89.9K | ﹤0.01% | 2561 |
|
|
2019
Q4 | $533K | Buy |
14,854
+2,139
| +17% | +$79.5K | ﹤0.01% | 2798 |
|
|
2019
Q3 | $445K | Buy |
12,715
+1,184
| +10% | +$45.5K | ﹤0.01% | 2844 |
|
|
2019
Q2 | $496K | Buy |
11,531
+999
| +9% | +$41.4K | ﹤0.01% | 2815 |
|
|
2019
Q1 | $455K | Sell |
10,532
-212,582
| -95% | -$8.55M | ﹤0.01% | 2790 |
|
|
2018
Q4 | $8.15M | Sell |
223,114
-13,037
| -6% | -$484K | 0.01% | 1593 |
|
|
2018
Q3 | $9.49M | Buy |
236,151
+7,963
| +3% | +$318K | 0.01% | 1679 |
|
|
2018
Q2 | $8.75M | Buy |
228,188
+25,562
| +13% | +$941K | 0.01% | 1689 |
|
|
2018
Q1 | $6.94M | Buy |
202,626
+6,477
| +3% | +$227K | 0.01% | 1752 |
|
|
2017
Q4 | $6.43M | Buy |
196,149
+7,165
| +4% | +$247K | 0.01% | 1786 |
|
|
2017
Q3 | $6.31M | Buy |
188,984
+11,593
| +7% | +$399K | 0.01% | 1751 |
|
|
2017
Q2 | $6.31M | Buy |
177,391
+6,184
| +4% | +$209K | 0.01% | 1672 |
|
|
2017
Q1 | $5.26M | Buy |
+171,207
| New | +$5.28M | 0.01% | 1731 |
|
Other funds holding QGEN
Charles Schwab's QGEN Position: Q2 2026 in Review
Charles Schwab increased its Qiagen (QGEN) stake by 8.3% in Q2 2026, buying an estimated $283K and bringing the position to 99,427 shares worth $3.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2573.
Charles Schwab first reported a position in QGEN in Q1 2017 and has held it in 38 quarters since. The position peaked at $9.49M in Q3 2018. 334 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- Charles Schwab held 99,427 shares of Qiagen worth $3.89M as of Q2 2026.
- Charles Schwab bought 7,623 Qiagen shares in Q2 2026, an estimated $283K.
- Qiagen made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2573 holding.
- Charles Schwab first reported a position in Qiagen in Q1 2017 and has held it in 38 quarters since.
- Charles Schwab's Qiagen position peaked at $9.49M in Q3 2018.
- 334 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.